Results for tag: "Allergic Rhinitis"

Allergic rhinitis, commonly known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Within the context of allergy and immunology, it is considered one of the most common conditions, affecting a substantial portion of the population. The market consists of various diagnostic and therapeutic options designed to manage and alleviate the symptoms of allergic rhinitis, which include sneezing, congestion, runny nose, and itchy eyes. Diagnostic methods range from skin prick tests to specific IgE blood tests, which help in identifying the allergens causing the symptoms. Treatment typically involves allergen avoidance strategies, pharmacotherapy, and immunotherapy. Pharmacologic treatments include antihistamines, decongestants, nasal corticosteroids, and leukotriene receptor antagonists. Subcutaneous and sublingual immunotherapies are approaches to desensitize the body's response to specific allergens. The market is driven by research and development of new treatments, improved diagnostics, and the rising prevalence of allergic diseases. Several companies that operate in the allergic rhinitis market include Merck & Co., Sanofi, GlaxoSmithKline, Johnson & Johnson, Novartis, AstraZeneca, and Pfizer. These entities engage in the manufacture and distribution of various medications, and some also provide immunotherapy options. These companies play a pivotal role in advancing the field of allergy and immunology through continuous Show Less Read more